Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.02
THC's Cash to Debt is ranked lower than
93% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 0.30 vs. THC: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
THC' s 10-Year Cash to Debt Range
Min: 0  Med: 0.04 Max: 0.35
Current: 0.02
0
0.35
Equity to Asset 0.04
THC's Equity to Asset is ranked lower than
90% of the 207 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. THC: 0.04 )
Ranked among companies with meaningful Equity to Asset only.
THC' s 10-Year Equity to Asset Range
Min: 0  Med: 0.21 Max: 0.43
Current: 0.04
0
0.43
Interest Coverage 1.23
THC's Interest Coverage is ranked lower than
85% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: 6.48 vs. THC: 1.23 )
Ranked among companies with meaningful Interest Coverage only.
THC' s 10-Year Interest Coverage Range
Min: 0.62  Med: 1.74 Max: 6.4
Current: 1.23
0.62
6.4
F-Score: 7
Z-Score: 1.08
WACC vs ROIC
6.02%
35.08%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 5.70
THC's Operating margin (%) is ranked lower than
59% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 7.11 vs. THC: 5.70 )
Ranked among companies with meaningful Operating margin (%) only.
THC' s 10-Year Operating margin (%) Range
Min: -14.26  Med: 5.97 Max: 15.05
Current: 5.7
-14.26
15.05
Net-margin (%) 0.32
THC's Net-margin (%) is ranked lower than
71% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 3.47 vs. THC: 0.32 )
Ranked among companies with meaningful Net-margin (%) only.
THC' s 10-Year Net-margin (%) Range
Min: -32  Med: 0.95 Max: 13.5
Current: 0.32
-32
13.5
ROE (%) 7.46
THC's ROE (%) is ranked lower than
56% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 8.83 vs. THC: 7.46 )
Ranked among companies with meaningful ROE (%) only.
THC' s 10-Year ROE (%) Range
Min: -124.98  Med: 5.17 Max: 92.79
Current: 7.46
-124.98
92.79
ROA (%) 0.30
THC's ROA (%) is ranked lower than
70% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 3.60 vs. THC: 0.30 )
Ranked among companies with meaningful ROA (%) only.
THC' s 10-Year ROA (%) Range
Min: -25.08  Med: 0.64 Max: 13.89
Current: 0.3
-25.08
13.89
ROC (Joel Greenblatt) (%) 10.92
THC's ROC (Joel Greenblatt) (%) is ranked lower than
61% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 15.83 vs. THC: 10.92 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
THC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -19.39  Med: 11.03 Max: 29.3
Current: 10.92
-19.39
29.3
Revenue Growth (3Y)(%) 32.40
THC's Revenue Growth (3Y)(%) is ranked higher than
96% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. THC: 32.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
THC' s 10-Year Revenue Growth (3Y)(%) Range
Min: -13.7  Med: -0.25 Max: 32.4
Current: 32.4
-13.7
32.4
EBITDA Growth (3Y)(%) 31.20
THC's EBITDA Growth (3Y)(%) is ranked higher than
90% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 7.60 vs. THC: 31.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
THC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -47.2  Med: 7.75 Max: 31.5
Current: 31.2
-47.2
31.5
EPS Growth (3Y)(%) -15.30
THC's EPS Growth (3Y)(%) is ranked lower than
79% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. THC: -15.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
THC' s 10-Year EPS Growth (3Y)(%) Range
Min: -69.8  Med: -5.30 Max: 57
Current: -15.3
-69.8
57
» THC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

THC Guru Trades in Q3 2014

Ken Heebner 1,965,000 sh (New)
Jim Simons 68,475 sh (New)
Louis Moore Bacon 162,451 sh (+4.91%)
Vanguard Health Care Fund 1,460,000 sh (+4.29%)
Larry Robbins 13,812,831 sh (unchged)
Ray Dalio Sold Out
George Soros Sold Out
Manning & Napier Advisors, Inc 187,190 sh (-15.06%)
Mario Gabelli 10,000 sh (-33.33%)
» More
Q4 2014

THC Guru Trades in Q4 2014

Steven Cohen 54,500 sh (New)
Paul Tudor Jones 8,903 sh (New)
Jim Simons 339,175 sh (+395.33%)
Mario Gabelli 15,000 sh (+50.00%)
Vanguard Health Care Fund 1,460,000 sh (unchged)
Larry Robbins 13,812,831 sh (unchged)
Manning & Napier Advisors, Inc Sold Out
Ken Heebner Sold Out
Louis Moore Bacon 21,999 sh (-86.46%)
» More
Q1 2015

THC Guru Trades in Q1 2015

Richard Perry 1,580,000 sh (New)
Paul Singer 1,022,000 sh (New)
Paul Singer 1,022,000 sh (New)
Vanguard Health Care Fund 2,053,200 sh (+40.63%)
Louis Moore Bacon 27,424 sh (+24.66%)
Mario Gabelli 15,050 sh (+0.33%)
Larry Robbins 13,812,831 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
Paul Tudor Jones 7,185 sh (-19.30%)
» More
Q2 2015

THC Guru Trades in Q2 2015

Steven Cohen 4,000 sh (New)
Joel Greenblatt 20,284 sh (New)
Jim Simons 37,775 sh (New)
Louis Moore Bacon 170,176 sh (+520.54%)
Paul Tudor Jones 19,326 sh (+168.98%)
Larry Robbins 14,792,313 sh (+7.09%)
Mario Gabelli 15,050 sh (unchged)
Paul Singer Sold Out
Richard Perry Sold Out
Vanguard Health Care Fund 1,399,100 sh (-31.86%)
» More
» Details

Insider Trades

Latest Guru Trades with THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 96.70
THC's P/E(ttm) is ranked lower than
90% of the 151 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. THC: 96.70 )
Ranked among companies with meaningful P/E(ttm) only.
THC' s 10-Year P/E(ttm) Range
Min: 1.87  Med: 19.59 Max: 978.3
Current: 96.7
1.87
978.3
Forward P/E 18.12
THC's Forward P/E is ranked higher than
52% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 19.76 vs. THC: 18.12 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 94.70
THC's PE(NRI) is ranked lower than
89% of the 149 Companies
in the Global Medical Care industry.

( Industry Median: 27.90 vs. THC: 94.70 )
Ranked among companies with meaningful PE(NRI) only.
THC' s 10-Year PE(NRI) Range
Min: 1.51  Med: 19.11 Max: 1296
Current: 94.7
1.51
1296
P/B 6.14
THC's P/B is ranked lower than
86% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. THC: 6.14 )
Ranked among companies with meaningful P/B only.
THC' s 10-Year P/B Range
Min: 1.24  Med: 5.08 Max: 101.5
Current: 6.14
1.24
101.5
P/S 0.27
THC's P/S is ranked higher than
92% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. THC: 0.27 )
Ranked among companies with meaningful P/S only.
THC' s 10-Year P/S Range
Min: 0.05  Med: 0.34 Max: 0.72
Current: 0.27
0.05
0.72
PFCF 190.73
THC's PFCF is ranked lower than
98% of the 117 Companies
in the Global Medical Care industry.

( Industry Median: 24.04 vs. THC: 190.73 )
Ranked among companies with meaningful PFCF only.
THC' s 10-Year PFCF Range
Min: 17.82  Med: 129.79 Max: 676
Current: 190.73
17.82
676
POCF 6.39
THC's POCF is ranked higher than
88% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 15.33 vs. THC: 6.39 )
Ranked among companies with meaningful POCF only.
THC' s 10-Year POCF Range
Min: 1.31  Med: 7.23 Max: 20.72
Current: 6.39
1.31
20.72
EV-to-EBIT 20.06
THC's EV-to-EBIT is ranked lower than
51% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 19.71 vs. THC: 20.06 )
Ranked among companies with meaningful EV-to-EBIT only.
THC' s 10-Year EV-to-EBIT Range
Min: -2497.3  Med: 11.70 Max: 31.8
Current: 20.06
-2497.3
31.8
PEG 6.76
THC's PEG is ranked lower than
84% of the 69 Companies
in the Global Medical Care industry.

( Industry Median: 2.77 vs. THC: 6.76 )
Ranked among companies with meaningful PEG only.
THC' s 10-Year PEG Range
Min: 2.46  Med: 4.77 Max: 31.32
Current: 6.76
2.46
31.32
Shiller P/E 31.97
THC's Shiller P/E is ranked lower than
58% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 30.72 vs. THC: 31.97 )
Ranked among companies with meaningful Shiller P/E only.
THC' s 10-Year Shiller P/E Range
Min: 15.18  Med: 27.50 Max: 692
Current: 31.97
15.18
692
Current Ratio 1.59
THC's Current Ratio is ranked higher than
60% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. THC: 1.59 )
Ranked among companies with meaningful Current Ratio only.
THC' s 10-Year Current Ratio Range
Min: 1.15  Med: 1.52 Max: 2.38
Current: 1.59
1.15
2.38
Quick Ratio 1.52
THC's Quick Ratio is ranked higher than
63% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. THC: 1.52 )
Ranked among companies with meaningful Quick Ratio only.
THC' s 10-Year Quick Ratio Range
Min: 1.05  Med: 1.41 Max: 2.29
Current: 1.52
1.05
2.29
Days Inventory 8.73
THC's Days Inventory is ranked higher than
70% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 17.13 vs. THC: 8.73 )
Ranked among companies with meaningful Days Inventory only.
THC' s 10-Year Days Inventory Range
Min: 8.46  Med: 12.37 Max: 21.55
Current: 8.73
8.46
21.55
Days Sales Outstanding 52.05
THC's Days Sales Outstanding is ranked lower than
62% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 46.03 vs. THC: 52.05 )
Ranked among companies with meaningful Days Sales Outstanding only.
THC' s 10-Year Days Sales Outstanding Range
Min: 46.89  Med: 61.48 Max: 87.69
Current: 52.05
46.89
87.69

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.85
THC's Price/Median PS Value is ranked higher than
80% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 1.11 vs. THC: 0.85 )
Ranked among companies with meaningful Price/Median PS Value only.
THC' s 10-Year Price/Median PS Value Range
Min: 0.19  Med: 1.48 Max: 5.28
Current: 0.85
0.19
5.28
Price/Peter Lynch Fair Value 4.36
THC's Price/Peter Lynch Fair Value is ranked lower than
87% of the 53 Companies
in the Global Medical Care industry.

( Industry Median: 2.47 vs. THC: 4.36 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
THC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.49  Med: 2.57 Max: 12.01
Current: 4.36
0.49
12.01
Earnings Yield (Greenblatt) (%) 5.00
THC's Earnings Yield (Greenblatt) (%) is ranked higher than
59% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. THC: 5.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
THC' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 3.1  Med: 7.60 Max: 10.6
Current: 5
3.1
10.6
Forward Rate of Return (Yacktman) (%) 20.89
THC's Forward Rate of Return (Yacktman) (%) is ranked higher than
78% of the 104 Companies
in the Global Medical Care industry.

( Industry Median: 11.17 vs. THC: 20.89 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
THC' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -103.1  Med: 0.40 Max: 21.1
Current: 20.89
-103.1
21.1

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 18,520 19,531 20,805
EPS($) 2.13 2.62 3.68
EPS without NRI($) 2.13 2.62 3.68

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:THC1.Germany,
Tenet Healthcare Corp, a Nevada corporation was incorporated in 1975. It is an investor-owned company whose subsidiaries and affiliates operate regionally focused, integrated health care delivery networks with a significant presence in several large urban and suburban markets. At the core of its networks are acute care and specialty hospitals that, together with its strategically aligned outpatient facilities and related businesses, allow them to provide a comprehensive range of health care services in the communities they serve. The Company primarily operated 77 hospitals, 183 outpatient centers, six health plans, six accountable care networks and Conifer Health Solutions, LLC ("Conifer"), which provides business process solutions to more than 700 hospital and other clients nationwide. It provides comprehensive operational management for revenue cycle functions, including patient access, health information management, revenue integrity and patient financial services. They also offer communications and engagement solutions to optimize the relationship between providers and patients. In addition, its management services offerings have expanded to support value-based performance through clinical integration, financial risk management and population health management. For financial reporting purposes, its business lines are classified into two separate reportable business segments — hospital operations and other, and Conifer. Its subsidiaries operated 77 hospitals, including four academic medical centers, two children's hospitals, three specialty hospitals and a critical access hospital, with a total of 20,293 licensed beds, serving primarily urban and suburban communities in 14 states. Of those hospitals, 72 were owned by its subsidiaries, and five were owned by third parties and leased by its subsidiaries. They are also in the process of constructing the new Resolute Health Hospital and Wellness Campus in New Braunfels, Texas, which is expected to be completed in or around May 2014. In addition, its subsidiaries operated a long-term acute care hospital and owned or leased and operated a number of medical office buildings, all of which were located on, or nearby, its hospital campuses. Furthermore, its subsidiaries operated 183 free-standing and provider-based outpatient centers in 16 states including diagnostic imaging centers, ambulatory surgery centers, urgent care centers and satellite emergency departments, among others. They also owned over 500 physician practices. Many of its hospitals also offer a wide range of clinical research studies, giving patients access to innovative care. The Company also own or control six accountable care networks — in Florida, California, Illinois, Michigan and Texas — and participate in two additional accountable care networks through collaborations with other health care providers in its markets in Arizona and Massachusetts. These networks operate using a range of payment and delivery mod
» More Articles for THC

Headlines

Articles On GuruFocus.com
Obamacare Makes HCA a Buy Aug 24 2015 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
THC BioMed Announces J.D. Springett Joins Advisory Board Jul 29 2015 
Don Shaxon Joins Advisory Board of THC BioMed Intl Ltd. Jul 22 2015 
THC BioMed Executes Definitive Agreement Jul 16 2015 
Damien Reynolds Appointed Chief Capital Markets Officer Jul 14 2015 
Distressed Debt Investor Paul Singer Buys Citrix Systems Jun 11 2015 
Humana And Concentra To Part Ways Mar 27 2015 
Tenet Healthcare And United Surgical JV For $1.93 Billion Mar 24 2015 
Mario Gabelli’s Equity Income Fund Q3 2014 Commentary Oct 29 2014 

More From Other Websites
Hospital powerhouse forged in the wake of Katrina Aug 27 2015
5 Stocks Insiders Love Right Now Aug 26 2015
Larry Robbins Continues To Believe In Tenet Healthcare Corp. (THC)’s Future Aug 26 2015
Healthcare's Coming Black Swan Events Aug 23 2015
Conifer Health Solutions Appoints James F. Brashear Senior Vice President and Chief Legal Officer Aug 18 2015
Key Insider Buying in Twitter, Level 3, Sears, MBIA and More Aug 15 2015
Strong Job Additions Spook US Equities Aug 13 2015
Insurance rate hikes Aug 11 2015
Can small & rural hospitals keep up? Aug 11 2015
Health care merger pressures Aug 11 2015
Larry Robbins Keeps Buying Shares of Tenet Healthcare Corp. (THC) Aug 10 2015
TENET HEALTHCARE CORP Financials Aug 08 2015
10-Q for Tenet Healthcare Corp. Aug 05 2015
Edited Transcript of THC earnings conference call or presentation 4-Aug-15 2:00pm GMT Aug 04 2015
Tenet Healthcare (THC) Tops Q2 Earnings, Updates Outlook - Analyst Blog Aug 04 2015
Tenet Healthcare Loss Widens Aug 03 2015
Monday's After-Hours Movers Led By Ctrip.com, Texas Roadhouse And Tenet Healthcare Aug 03 2015
Tenet Healthcare (THC) Stock Climbs in After-Hours Trading on Earnings Beat Aug 03 2015
Tenet Healthcare raises full-year outlook Aug 03 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK